Extracellular Vesicle-Based Therapies for Osteoarthritis-Advances, Challenges and Hopes

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Osteoarthritis Research

Background:

• Osteoarthritis (OA) significantly impacts aging populations, causing pain and disability.
• Current OA treatments offer only symptomatic relief, necessitating disease-modifying approaches.
• Extracellular vesicles (EVs) are emerging as potential next-generation therapeutics for OA.

Purpose of the Study:

• To review recent advancements in extracellular vesicle (EV)-based therapies for osteoarthritis (OA).
• To discuss the primary challenges hindering the clinical application of EV therapies for OA.
• To highlight the potential of EVs in transforming OA treatment paradigms.

Main Methods:

• Review of current literature on extracellular vesicle (EV) applications in osteoarthritis (OA) research.
• Analysis of the mechanisms by which EVs modulate the OA microenvironment.
• Identification of key challenges and future directions for EV-based OA therapies.

Main Results:

• Extracellular vesicles (EVs) demonstrate potential to modulate inflammation within the OA joint.
• EVs can reshape the OA microenvironment, promoting tissue repair and regeneration.
• Recent studies indicate EVs as promising candidates for disease-modifying OA therapies.

Conclusions:

• Extracellular vesicles (EVs) represent a promising frontier for osteoarthritis (OA) treatment.
• Addressing current challenges in EV production and delivery is crucial for clinical translation.
• EV-based therapies hold significant hope for redefining the future of osteoarthritis management.